findmyKOL
Clinical trialNCT05804370RecruitingPhase 3Interventional

Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)

SponsorNX Development CorpEnrollment170Ovarian Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Mayo Clinic Arizona

    Phoenix, Arizona, United States

    Kristina Butler, MD
    Recruiting
  • Luminis Health Anne Arundel Medical Center

    Annapolis, Maryland, United States

    Terminated
  • University of Maryland

    Baltimore, Maryland, United States

    Dana Roque, MD
    Recruiting
  • Mayo Clinic Methodist Campus

    Rochester, Minnesota, United States

    Amanika Kumar, MD
    Recruiting
  • Mount Sinai

    New York, New York, United States

    Stephanie Blank, MD
    Recruiting
  • Wellspan Health

    York, Pennsylvania, United States

    Eav Lim, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 May 2024
Primary completion
31 Jan 2027
Completion
31 May 2027
Last update posted
1 Oct 2025
Registered enrollment
170
Registry id
NCT05804370

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.